Dr. Charmaine Lok is the new chairperson of the PatenSee Scientific Advisory Board. The company also announced this week that Dr. Allen R. Nissenson has joined the company as a strategic advisor. PatenSee is developing a contactless imaging system to provide rapid vascular access monitoring for hemodialysis patients.
Follow Israel Hayom on Facebook, Twitter, and Instagram
Lok is a professor of medicine at the University of Toronto and senior scientist at the Toronto General Hospital Research Institute. She is also the medical director of both the chronic kidney diseases and hemodialysis programs at the University Health Network, Toronto, Canada. Her research focuses on kidney failure outcomes, with a special interest in vascular access, cardiovascular events prevention, and innovation.
"Effective monitoring of vascular access is a major clinical unmet need. PatenSee's system harnesses imaging technology to potentially enhance the quality and reliability of fistula monitoring with the goal of early detection and treatment of clinically significant stenosis that in many cases lead to serious complications. I am delighted to join PatenSee as the chairperson of its Scientific Advisory Board and look forward to guiding this technology's further development to rapidly make it available for improving patient outcomes," said Dr. Lok.
Nissenson is the co-founder of Renal Care Innovation Holdings, a company dedicated to accelerating the availability of innovative drugs, devices and care delivery models for patients with kidney diseases.
"Today, nurses manually check for stenosis in the fistula, the point of connection between the patient and the dialysis machine. PatenSee's technology will help expedite the process by providing a rapid and clear reading of the fistula's status. It's important work with the potential to significantly improve patient outcomes," Nissenson said.
